US 6699994
Biaryl compounds as serine protease inhibitors
expired A61KA61K31/192A61K31/341
Quick answer
US patent 6699994 (Biaryl compounds as serine protease inhibitors) held by BioCryst Pharmaceuticals, Inc. expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/192, A61K31/341, A61K31/381, A61K31/426